# BPIFA2

## Overview
BPIFA2, or BPI fold containing family A member 2, is a gene that encodes the protein known as SPLUNC2, which is part of the BPI fold-containing superfamily. This protein plays a crucial role in the innate immune system, particularly in mucosal immunity within the oral cavity and respiratory tract. BPIFA2 is predominantly expressed in the salivary glands and contributes significantly to the antimicrobial and anti-inflammatory properties of saliva. The protein interacts with bacterial components such as lipopolysaccharides, aiding in the defense against pathogenic bacteria. Additionally, BPIFA2 is involved in maintaining the physical properties of saliva, which are essential for its proper functioning in the oral cavity. The gene and its protein product are also implicated in various clinical conditions, including autoimmune diseases and responses to infections, highlighting their importance in both local and systemic physiological processes (Nandula2020The; Prokopovic2014Isolation).

## Structure
BPIFA2, also known as SPLUNC2, is a protein that belongs to the BPI fold-containing superfamily, characterized by a BPI domain crucial for lipid binding and immune response functions. The protein exhibits a molecular weight of approximately 25 kDa after the proteolysis of the signal peptide and shows microheterogeneity, suggesting the presence of at least two different forms. One form is slightly less than 25 kDa with a pI of 5.3, and the more abundant form is about 25 kDa with a pI of 4.9 (Prokopovic2014Isolation). 

The protein does not exhibit differential electrophoretic mobility under reducing and non-reducing conditions, indicating a limited number or absence of disulfide bridges, which suggests minimal involvement of disulfide bonds in its tertiary structure (Prokopovic2014Isolation). BPIFA2 is heavily glycosylated, a significant post-translational modification that could influence its stability and function (Bingle2011Distribution).

Despite the lack of detailed structural data, the presence of the BPI fold typically involves a two-domain structure, which might suggest a similar organization in BPIFA2, although this has not been explicitly confirmed for this protein (Bingle2011Systematic).

## Function
BPIFA2, also known as parotid secretory protein (PSP) or SPLUNC2, is a protein that plays a significant role in the innate immune defense, particularly in the oral cavity and potentially in the upper respiratory pathways. It is expressed predominantly in the salivary glands and is a major component of saliva. BPIFA2 is involved in the local antibacterial response at mucosal sites by binding to lipopolysaccharides (LPS), which are components of the outer membrane of Gram-negative bacteria. This interaction suggests a protective function against pathogens by inhibiting bacterial growth and potentially neutralizing the effects of LPS, thus contributing to the antimicrobial and anti-inflammatory activities of saliva (Nandula2020The; Prokopovic2014Isolation).

The protein is also noted for its role in maintaining the physical properties of saliva, such as surface tension and wetting ability, which are crucial for the proper functioning of saliva in the oral cavity. In knockout mice models lacking BPIFA2, saliva exhibited higher surface tension and reduced spreading capability on hydrophobic surfaces, underscoring its significance in saliva's surfactant properties (Nandula2020The).

Furthermore, BPIFA2 has been implicated in systemic metabolic effects, as observed in changes in metabolite concentrations in knockout mice, suggesting that its influence extends beyond local sites of expression (Nandula2020The). This broad range of functions highlights the importance of BPIFA2 in both local defense mechanisms and potentially in systemic physiological processes.

## Clinical Significance
BPIFA2 has been implicated in several clinical conditions, particularly in relation to its role in mucosal defense and immune response. Alterations in BPIFA2 expression or mutations in the gene have been associated with SjÃ¶gren's syndrome, a chronic autoimmune disease that affects the body's moisture-producing glands. Research using NOD mice models has shown that depletion of BPIFA2 leads to SjÃ¶gren's syndrome-like symptoms, and BPIFA2 autoantibodies have been detected in patients with the syndrome (Nandula2020The). Additionally, studies on the effects of head and neck cancer radiotherapy have revealed significant changes in BPIFA2 expression. Post-radiotherapy, patients exhibit decreased levels of glycosylated BPIFA2, which correlates with the development of mucositis, a painful inflammation and ulceration of the mucous membranes lining the digestive tract (GonzÃ¡lez-Arriagada2015Salivary).

Furthermore, BPIFA2 is also considered a potential biomarker for acute kidney injury (AKI) in septic conditions. Its expression is upregulated in renal progenitor cells in response to lipopolysaccharide (LPS) stimulation, which is a common occurrence in sepsis (Sallustio2019RenalPC). This suggests a protective role of BPIFA2 against kidney damage and fibrosis by modulating the local immune response during septic conditions.

## Interactions
BPIFA2, also known as SPLUNC2, interacts with Candida albicans by acting as a receptor that facilitates the yeast's adherence to silicone surfaces, which is particularly relevant in the context of silicone voice prostheses. This interaction is specific and dose-dependent, as demonstrated by adherence assays where radiolabelled C. albicans cells adhered to SPLUNC2-coated silicone in a manner that was significantly higher compared to controls (Holmes2014Adherence). Additionally, BPIFA2 has demonstrated antibacterial activity, particularly against Pseudomonas aeruginosa. This activity includes binding to bacterial lipopolysaccharide (LPS), which suggests a direct interaction between BPIFA2 and bacterial components that may inhibit bacterial growth (Prokopovic2014Isolation). However, the specific molecular details of these interactions, such as binding to proteins or nucleic acids within bacterial cells, have not been fully elucidated in the provided excerpts. Thus, while BPIFA2 is known to interact with microbial cells, further research is necessary to clarify the exact nature of these interactions at the molecular level.


## References


[1. (Holmes2014Adherence) A.R. Holmes, E. Rodrigues, P. van der Wielen, K.M. Lyons, B.J. Haigh, T.T. Wheeler, P.J.D. Dawes, and R.D. Cannon. Adherence of candida albicans to silicone is promoted by the human salivary protein <scp>splunc</scp>2/<scp>psp</scp>/<scp>bpifa</scp>2. Molecular Oral Microbiology, 29(2):90â98, February 2014. URL: http://dx.doi.org/10.1111/omi.12048, doi:10.1111/omi.12048. (20 citations) 10.1111/omi.12048](https://doi.org/10.1111/omi.12048)

[2. (Nandula2020The) Seshagiri Rao Nandula, Ian Huxford, Thomas T. Wheeler, Conrado Aparicio, and SvenâUlrik Gorr. The parotid secretory protein bpifa2 is a salivary surfactant that affects lipopolysaccharide action. Experimental Physiology, 105(8):1280â1292, June 2020. URL: http://dx.doi.org/10.1113/EP088567, doi:10.1113/ep088567. (8 citations) 10.1113/EP088567](https://doi.org/10.1113/EP088567)

[3. (GonzÃ¡lez-Arriagada2015Salivary) Wilfredo Alejandro GonzÃ¡lez-Arriagada, Lara Maria Alencar Ramos, Andreia Aparecida Silva, Pablo Agustin Vargas, Ricardo Della Coletta, Lynne Bingle, and Marcio Ajudarte Lopes. Salivary bpifa1 (splunc1) and bpifa2 (splunc2 a) are modified by head and neck cancer radiotherapy. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 119(1):48â58, January 2015. URL: http://dx.doi.org/10.1016/j.oooo.2014.09.026, doi:10.1016/j.oooo.2014.09.026. (14 citations) 10.1016/j.oooo.2014.09.026](https://doi.org/10.1016/j.oooo.2014.09.026)

[4. (Sallustio2019RenalPC) F. Sallustio, A. Stasi, C. Curci, C. Divella, A. Picerno, R. Franzin, G. De Palma, M. Rutigliano, G. Lucarelli, M. Battaglia, F. Staffieri, A. Crovace, G. Pertosa, G. Castellano, A. Gallone, and L. Gesualdo. Renal progenitor cells revert lpsâinduced endothelialâtoâmesenchymal transition by secreting cxcl6, saa4, and bpifa2 antiseptic peptides. The FASEB Journal, 33:10753 - 10766, 2019. (24 citations) 10.1096/fj.201900351R](https://doi.org/10.1096/fj.201900351R)

[5. (Bingle2011Distribution) Lynne Bingle and Colin D. Bingle. Distribution of human plunc/bpi fold-containing (bpif) proteins. Biochemical Society Transactions, 39(4):1023â1027, July 2011. URL: http://dx.doi.org/10.1042/bst0391023, doi:10.1042/bst0391023. (74 citations) 10.1042/bst0391023](https://doi.org/10.1042/bst0391023)

[6. (Prokopovic2014Isolation) Vladimir Prokopovic, Milica Popovic, Uros Andjelkovic, Aleksandra Marsavelski, Brankica Raskovic, Marija Gavrovic-Jankulovic, and Natalija Polovic. Isolation, biochemical characterization and anti-bacterial activity of bpifa2 protein. Archives of Oral Biology, 59(3):302â309, March 2014. URL: http://dx.doi.org/10.1016/j.archoralbio.2013.12.005, doi:10.1016/j.archoralbio.2013.12.005. (24 citations) 10.1016/j.archoralbio.2013.12.005](https://doi.org/10.1016/j.archoralbio.2013.12.005)

[7. (Bingle2011Systematic) Colin D. Bingle, Ruth L. Seal, and C. Jeremy Craven. Systematic nomenclature for the plunc/psp/bsp30/smgb proteins as a subfamily of the bpi fold-containing superfamily. Biochemical Society Transactions, 39(4):977â983, July 2011. URL: http://dx.doi.org/10.1042/bst0390977, doi:10.1042/bst0390977. (90 citations) 10.1042/bst0390977](https://doi.org/10.1042/bst0390977)